| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 0 | 1.440.849 |
| Total Income - EUR | - | - | - | - | - | - | - | 4.520 | 172.599 | 6.746.543 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 4.520 | 172.599 | 6.474.151 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 0 | 0 | 272.392 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 0 | 0 | 272.392 |
| Employees | - | - | - | - | - | - | - | 0 | 0 | 1 |
Check the financial reports for the company - Genesis Bio Reinvest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 209.347 | 866.861 | 35.701.755 |
| Current Assets | - | - | - | - | - | - | - | 18.621 | 24.600 | 3.557.983 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 104.448 |
| Receivables | - | - | - | - | - | - | - | 1.590 | 12.722 | 1.490.686 |
| Cash | - | - | - | - | - | - | - | 17.032 | 11.878 | 170.418 |
| Shareholders Funds | - | - | - | - | - | - | - | 406 | 404 | 272.794 |
| Social Capital | - | - | - | - | - | - | - | 406 | 404 | 402 |
| Debts | - | - | - | - | - | - | - | 227.563 | 891.057 | 38.991.981 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Genesis Bio Reinvest S.r.l.